Last reviewed · How we verify
Cellular and tissue based products — Competitive Intelligence Brief
phase 2
Cellular and tissue-based products
Wound care
Biologic
Live · refreshed every 30 min
Target snapshot
Cellular and tissue based products (Cellular and tissue based products) — U.S. Wound Registry. This drug stimulates cellular and tissue repair.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cellular and tissue based products TARGET | Cellular and tissue based products | U.S. Wound Registry | phase 2 | Cellular and tissue-based products |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Cellular and tissue-based products class)
- U.S. Wound Registry · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cellular and tissue based products CI watch — RSS
- Cellular and tissue based products CI watch — Atom
- Cellular and tissue based products CI watch — JSON
- Cellular and tissue based products alone — RSS
- Whole Cellular and tissue-based products class — RSS
Cite this brief
Drug Landscape (2026). Cellular and tissue based products — Competitive Intelligence Brief. https://druglandscape.com/ci/cellular-and-tissue-based-products. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab